Bravura Solutions Limited (ASX:BVS – Get Free Report) insider Andrew Russell bought 67,565 shares of the company’s stock in a transaction that occurred on Thursday, September 21st. The stock was purchased at an average price of A$0.74 ($0.47) per share, with a total value of A$49,998.10 ($32,050.06). Bravura Solutions Price Performance The company has a […]
Bravura Solutions Limited (ASX:BVS – Get Free Report) insider Matthew Quinn purchased 100,000 shares of the business’s stock in a transaction dated Monday, August 28th. The stock was bought at an average cost of A$0.68 ($0.44) per share, for a total transaction of A$67,500.00 ($43,548.39). Matthew Quinn also recently made the following trade(s): On Friday, […]
Bioventus (NYSE:BVS – Get Free Report) and Nuvectra (OTCMKTS:NVTRQ – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Profitability This table compares Bioventus and Nuvectra’s net margins, return […]
Bioventus Inc. (NYSE:BVS – Get Free Report) major shareholder Juniper Investment Company, Ll acquired 14,985 shares of the business’s stock in a transaction on Monday, August 14th. The shares were bought at an average cost of $4.79 per share, with a total value of $71,778.15. Following the completion of the acquisition, the insider now owns […]
Bioventus Inc. (NYSE:BVS – Get Free Report) Director John A. Bartholdson acquired 111,848 shares of the business’s stock in a transaction dated Thursday, August 10th. The shares were acquired at an average cost of $4.47 per share, with a total value of $499,960.56. Following the acquisition, the director now directly owns 6,768,835 shares of the […]